In 2021, an international expert group convened by the ADA published a consensus report on the clinical definition of “remission” in type 2 diabetes.
News and Updates for Healthcare Professionals
Findings support personalized public health interventions to help close gaps.
An additional $22.3 billion is spent nationally on HF-related medical services each year, with the total annual expenditure for adults with HF approaching $180 billion, according to an analysis of Medical Expenditure Panel Survey data.
Study is one of the largest to look at the links between sleep quality and COPD flare-ups.
News and Updates for the Patient and Family
March is National Nutrition Month, and the U.S. Food and Drug Administration is shining a spotlight on the importance of good nutrition and the big impact it has on improving people’s lives and lowering the enormous costs of diet-related chronic diseases. Each year, more than a million Americans die from diet-related diseases like cardiovascular disease, diabetes and certain forms of cancers.…
The Roger C. Lipitz Center for Integrated Health Care is pleased to share the newly released Engaging and Supporting Family Caregivers in Care Delivery issue brief in this Winter 2022 Lipitz Quarterly Newsletter
Prediabetes is a serious health condition affecting 88 million Americans—more than 1 in 3 people—and most are unaware they have it. People with prediabetes have higher-than-normal blood sugar levels that aren’t yet high enough to be considered diabetes, and data shows that people with prediabetes have a 50% chance of developing type 2 diabetes within 5 to 10 years.
ODPHP has launched our updated toolkit for health professionals, with consumer-friendly fact sheets based on the Dietary Guidelines for Americans, 2020–2025.
WASHINGTON, D.C. - "Kidney transplant patients, based on the lifetime immunosuppressive medications they must take to stay alive, remain at severe risk of catastrophic illness and death due to COVID-19. The American Association of Kidney Patients (AAKP) thanks the U.S. Food and Drug Administration (FDA) for incorporating the unique insights of America's kidney transplant recipients and the medical professionals who care for them in their authorization of a third vaccine dose...